CUBE vs WST · P/E 25, rev $1.07B vs P/E 35, rev $2.89B
CubeSmart (CUBE) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the CUBE and WST stock pages for the full models.
Not investment advice.